Guangdong Biolight Meditech Co., Ltd.

Shenzhen Stock Exchange 300246.SZ

Guangdong Biolight Meditech Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2023: -2.57%

Guangdong Biolight Meditech Co., Ltd. Return on Assets (ROA) is -2.57% for the year ending December 31, 2023, a -383.42% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.
  • Guangdong Biolight Meditech Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2022 was 0.91%, a -75.54% change year over year.
  • Guangdong Biolight Meditech Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2021 was 3.71%, a -82.77% change year over year.
  • Guangdong Biolight Meditech Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2020 was 21.54%, a 219.99% change year over year.
  • Guangdong Biolight Meditech Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2019 was 6.73%, a -3.73% change year over year.
Key data
Date Return on Assets (ROA) Return on Equity (ROE) Return on Capital Employed (ROCE) Interest Coverage Ratio
Market news
Loading...
SV Wall Street
Shenzhen Stock Exchange: 300246.SZ

Guangdong Biolight Meditech Co., Ltd.

CEO Mr. Jinyuan Yan
IPO Date July 19, 2011
Location China
Headquarters No. 2 Innovation First Road
Employees 1,419
Sector Healthcare
Industries
Description

Guangdong Biolight Meditech Co., Ltd. engages in the research and development, marketing, sale, and service of medical devices, medical consumables, and healthcare solutions. The company offers patient monitors, ECG machines, fetal monitors, hemodialysis products, homecare medical products, medical pumps, veterinary monitors, and accessories. It operates in Asia, Africa, Europe, North America, and Latin America. Guangdong Biolight Meditech Co., Ltd. was founded in 1993 and is headquartered in Zhuhai, China.

StockViz Staff

February 2, 2025

Any question? Send us an email